Moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment of Rifampicin-Resistant Tuberculosis in Children

Moxifloxacin is a recommended drug for rifampin-resistant tuberculosis (RR-TB) treatment, but there is limited pediatric pharmacokinetic and safety data, especially in young children. We characterize moxifloxacin population pharmacokinetics and QT interval prolongation and evaluate optimal dosing in...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical infectious diseases Vol. 74; no. 8; p. 1372
Main Authors:	Radtke, Kendra K, Hesseling, Anneke C, Winckler, J L, Draper, Heather R, Solans, Belen P, Thee, Stephanie, Wiesner, Lubbe, van der Laan, Louvina E, Fourie, Barend, Nielsen, James, Schaaf, H Simon, Savic, Radojka M, Garcia-Prats, Anthony J
Format:	Journal Article
Language:	English
Published:	United States 28.04.2022
Subjects:	Adult Child Child, Preschool Electrocardiography Fluoroquinolones - adverse effects HIV Infections Humans Moxifloxacin - adverse effects Rifampin - adverse effects Rifampin - pharmacokinetics Tuberculosis - drug therapy Tuberculosis, Multidrug-Resistant - drug therapy pharmacokinetics pediatrics tuberculosis moxifloxacin
ISSN:	1537-6591, 1537-6591
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!